Effect of a high saturated fatty acids load on serum concentrations of C-reactive protein, α1-antitrypsin, fibrinogen and α1-acid glycoprotein in obese women;Evaluación del efecto de la ingesta de una alta carga de ácidos grasos saturados sobre los niveles séricos de la proteína C reactiva, α1-antitripsina, fibrinógeno y α1-glicoproteína ácida en mujeres obesas

Nutricion Hospitalaria

Volumn 25, Issue 1, 2010, Pages 72-79

  Alvarado, M M Ramírez ^a   Roitz, C Sánchez ^b   Díaz, A Pérez ^b   Brito, E Millán ^b  

^a UNIVERSIDAD DE CARABOBO   (Venezuela)

^b Centro Medico Dr Rafael Guerra Mendez   (Venezuela)

Author keywords

C reactive protein; Fibrinogen; Obesity; 1 acid glucoprotein; 1 antitrypsin

Indexed keywords

EID: 76449117518     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2010.25.1.4255     Document Type: Article

References (28)

1. Cancello R, Clement K. Is obesity and inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue. BJOG 2006; 113: 1141-1147.
2. Rasouli N, Kern PA. Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 2008; 93 (11 Supl. 1): S64-S73.
3. Ramírez A MM, Medina MA, Querales CM, Millán BE, Sánchez RCO. Evaluación del efecto de la ingesta de una sobrecarga de glucosa sobre los niveles séricos de la proteína C reactiva y de la á1-antitripsina en mujeres obesas. Nutr Hosp 2008; 23: 340-347.
4. Dietrich M, Jialal I. The effect of weight loss on a stable biomarker of inflammation, C-reactive protein. Nutr Rev 2005; 63: 22-28.
5. Anty R, Bekri S, Luciani N y cols. The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH. Am J Gastroenterol 2006; 101: 1-10.
6. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and others markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843. (Pubitemid 30165206)
7. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. Creactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001; 286: 327-334.
8. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
9. Moshage H. Cytokines and the hepatic acute phase response. J Pathol 1997; 181: 257-266.
10. Engstrom G, Lind P, Hedblad B, Stavenow L, Janzon L, Lindgarde F. Effects of cholesterol and inflammation-sensitive plasma protein on incidence of myocardial infarction and stroke in men. Circulation 2002; 105: 2632-2637.
11. Engstrom G, Stavenow L, Hedblad B y cols. Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke. Diabetes 2003; 52: 442-447. (Pubitemid 36173201)
12. Fain JN, Madan AK, Hiler L, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004; 145: 2273-2282.
13. Libby P. Inflammation in atherosclerosis. Nature 2002; 420: 868-874.
14. Baer DJ, Judd JT, Clevidence BA, Tracy RP. Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr 2004; 79: 969-973.
15. Mozaffarian D, Pischon T, Hankinson SE y cols. Dietary intake of trans fatty acids and systemic inflammation in women. Am J Clin Nutr 2004; 79: 606-612. (Pubitemid 41103904)
16. Tannock LR, O'Brien KD, Knopp RH y cols. Cholesterol feeding increases C-reactive protein and serum amyloid A levels in lean insulin-sensitive subjects. Circulation 2005; 111: 3058-3062.
17. Ceriello A, Taboga C, Tonutti L y cols. Evidence for an independent and cumulative effect of postprandial hypertriglyceridemia and hyperglycemia on endothelial dysfunction and oxidative stress generation: effects of short- and long-term simvastatin treatment. Circulation 2002; 106: 1211-1218.
18. Friedewald WT, Levy RI, Fredickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 8: 499-502.
19. Khaodhiar L, Ling PR, Blackburn GL, Bistrian BR. Serum levels of interleukin-6 and C-reactive protein correlate with body mass index across the broad range of obesity. J Parenter Enteral Nutr 2004; 28: 410-415.
20. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosisalpha in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
21. Mohamed-Ali V, Goodrick S, Rawesh A y cols. Subcutaneous adipose tissue releases interleukin-6, but no tumor necrosisalpha in vivo. J Clin Endocrinol Metab 1997; 82: 4196-4200.
22. Murakami K, Sasaki S, Takahashi Y y cols. Total n-3 polyunsaturated fatty acid intake is inversely associated with serum C-reactive protein in young japanese women. Nutr Res 2008; 28: 309-314.
23. Fredrikson GN, Hedblad B, Nilsson JA y cols. Association between diet, lifestyle, metabolic cardiovascular risk factors, and plasma C-reactive protein levels. Metabolism 2004; 53: 1436-1442.
24. Campbell CG, Brown BD, Dufner D, Thorland WG. Effects of soy or milk protein during a high-fat feeding challenge on oxidative stress, inflammation, and lipids in healthy men. Lipids 2006; 41: 257-265.
25. Engstrom G, Hedblad B, Stavenow L y cols. Incidence of obesity- associated cardiovascular disease is related to inflammation- sensitive plasma proteins. A population-based cohort study. Arterioscler Thromb Vasc Biol 2004; 24: 1498-1502.
26. Coppack SW. Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc 2001; 60: 349-356.
27. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
28. Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005; 40: 1215-1220.